Dr. Yong Zhang's lab at USC focuses on innovating therapies for triple negative breast cancer (TNBC), a challenging and aggressive form of cancer. They are developing engineered exosomes—small vesicles that can boost immune responses to target TNBC tumors. The research aims to create safer and more effective treatments, potentially transforming how TNBC is managed in clinical settings.